Biotech Firm Coming To Pearland

Lonza Group, a massive Swiss pharmaceutical company, plans to build a 100k SF biotech facility in Pearland that will replace Lonza’s existing Houston operations. The new facility will be on an 11-acre plot in Pearland’s Lower Kirby District.

The Pearland Economic Development Council and Lonza have been in discussions since 2014, according to the Houston Business Journal. Fort Worth-based Rogue Architects is the architect of record.

The new facility will have 100k SF of office space, labs and other areas that will facilitate the production of its viral gene and virally modified therapeutics. [HBJ]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Houston Newsletters
Related Stories

Power Availability Becomes New Requirement For Shifting Bay Area Industrial Base

Cross Ocean Partners, Fuller Realty Acquire 829K SF Houston Office Campus

Trammell Crow Starts Phase Of 2M SF Industrial Park: The Houston Deal Sheet

Oncology Company Expands Footprint At Hines' Life Sciences Campus

EXCLUSIVE: Industrial Outdoor Storage Investor Continues Buying Spree In Metro Atlanta

Amazon Building 1.2M SF Distribution Facility In Aurora

Starwood, Realterm Fund Record Industrial Outdoor Storage Loan

Astrodome Conservancy Solicits Redevelopment Ideas

Rexford To Sell $1.2B Industrial Portfolio As Part Of Plan To Increase Dispositions

Fake-Plant Maker Shuttering Hialeah Warehouse, Moving To Lakeland

Big-Box Deals Push Chicago Industrial Leasing Into National Top 3

Sugar Land Town Square Secures Fortune 500 Lease: The Houston Deal Sheet